Chae Hwa Kim

Title: Innovations of Chae Hwa Kim in Hemostasis and Wound Treatment

Introduction

Chae Hwa Kim is an accomplished inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the area of hemostasis and wound treatment. His innovative work has led to the development of a unique foam that addresses critical needs in medical applications.

Latest Patents

Chae Hwa Kim holds a patent for "Carboxylmethyl cellulose foam for hemostasis and wound treatment, and method for preparing same." This invention relates to a highly liquid absorbent and hardly water-soluble carboxymethyl cellulose (CMC) foam. The foam is designed to absorb body fluid or water, expand in volume when absorbing liquid, and maintain its shape without gelling. The CMC foam exhibits superior liquid absorption properties and is particularly effective as a hemostatic agent and wound dressing. Additionally, treatment with a CMC powder dispersing liquid enhances its surface characteristics, preventing adhesion with the skin and improving liquid retention capability.

Career Highlights

Chae Hwa Kim is affiliated with the Korea Institute of Industrial Technology, where he continues to advance his research and development efforts. His work has garnered attention for its practical applications in healthcare, particularly in improving patient outcomes through innovative materials.

Collaborations

Chae Hwa Kim has collaborated with notable colleagues, including Song Jun Doh and Jung Nam Im. These partnerships have contributed to the successful development and refinement of his patented technologies.

Conclusion

Chae Hwa Kim's contributions to the field of hemostasis and wound treatment through his innovative CMC foam demonstrate the potential of his inventions to improve medical practices. His work exemplifies the importance of research and innovation in addressing healthcare challenges.